Study of ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolar Disorder in Adults

NCT06869187 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder Depression

Interventions

DRUG: ABX-002

Sponsor

Autobahn Therapeutics, Inc.